412 related articles for article (PubMed ID: 33249434)
1. Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression.
Rivas-Grajales AM; Salas R; Robinson ME; Qi K; Murrough JW; Mathew SJ
Int J Neuropsychopharmacol; 2021 May; 24(5):383-391. PubMed ID: 33249434
[TBL] [Abstract][Full Text] [Related]
2. Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression.
Taraku B; Loureiro JR; Sahib AK; Zavaliangos-Petropulu A; Al-Sharif N; Leaver AM; Wade B; Joshi S; Woods RP; Espinoza R; Narr KL
Brain Behav; 2024 Jun; 14(6):e3511. PubMed ID: 38894648
[TBL] [Abstract][Full Text] [Related]
3. Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment-resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans.
Zhuo C; Tian H; Li G; Chen M; Jiang D; Lin X; Xu Y; Wang W
Brain Behav; 2019 Nov; 9(11):e01423. PubMed ID: 31617335
[TBL] [Abstract][Full Text] [Related]
4. Differences between ketamine's short-term and long-term effects on brain circuitry in depression.
Gass N; Becker R; Reinwald J; Cosa-Linan A; Sack M; Weber-Fahr W; Vollmayr B; Sartorius A
Transl Psychiatry; 2019 Jun; 9(1):172. PubMed ID: 31253763
[TBL] [Abstract][Full Text] [Related]
5. Functional Dysconnectivity of Frontal Cortex to Striatum Predicts Ketamine Infusion Response in Treatment-Resistant Depression.
Chen MH; Chang WC; Lin WC; Tu PC; Li CT; Bai YM; Tsai SJ; Huang WS; Su TP
Int J Neuropsychopharmacol; 2020 Dec; 23(12):791-798. PubMed ID: 32726408
[TBL] [Abstract][Full Text] [Related]
6. Functional connectivity between the habenula and default mode network and its association with the antidepressant effect of ketamine.
Wang M; Chen X; Hu Y; Zhou Y; Wang C; Zheng W; Liu W; Lan X; Ning Y; Zhang B
Depress Anxiety; 2022 May; 39(5):352-362. PubMed ID: 34964207
[TBL] [Abstract][Full Text] [Related]
7. Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.
Ionescu DF; Felicione JM; Gosai A; Cusin C; Shin P; Shapero BG; Deckersbach T
Harv Rev Psychiatry; 2018; 26(6):320-339. PubMed ID: 29465479
[TBL] [Abstract][Full Text] [Related]
8. Ketamine Treatment and Global Brain Connectivity in Major Depression.
Abdallah CG; Averill LA; Collins KA; Geha P; Schwartz J; Averill C; DeWilde KE; Wong E; Anticevic A; Tang CY; Iosifescu DV; Charney DS; Murrough JW
Neuropsychopharmacology; 2017 May; 42(6):1210-1219. PubMed ID: 27604566
[TBL] [Abstract][Full Text] [Related]
9. Resting-State Functional Connectivity of the Habenula in Mood Disorder Patients With and Without Suicide-Related Behaviors.
Ambrosi E; Arciniegas DB; Curtis KN; Patriquin MA; Spalletta G; Sani G; Frueh BC; Fowler JC; Madan A; Salas R
J Neuropsychiatry Clin Neurosci; 2019; 31(1):49-56. PubMed ID: 30282513
[TBL] [Abstract][Full Text] [Related]
10. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
Carlson PJ; Diazgranados N; Nugent AC; Ibrahim L; Luckenbaugh DA; Brutsche N; Herscovitch P; Manji HK; Zarate CA; Drevets WC
Biol Psychiatry; 2013 Jun; 73(12):1213-21. PubMed ID: 23540908
[TBL] [Abstract][Full Text] [Related]
11. Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.
Cornwell BR; Salvadore G; Furey M; Marquardt CA; Brutsche NE; Grillon C; Zarate CA
Biol Psychiatry; 2012 Oct; 72(7):555-61. PubMed ID: 22521148
[TBL] [Abstract][Full Text] [Related]
12. Ketamine treatment modulates habenular and nucleus accumbens static and dynamic functional connectivity in major depression.
Taraku B; Loureiro JR; Sahib AK; Zavaliangos-Petropulu A; Al-Sharif N; Leaver A; Wade B; Joshi S; Woods RP; Espinoza R; Narr KL
medRxiv; 2023 Dec; ():. PubMed ID: 38106178
[TBL] [Abstract][Full Text] [Related]
13. Habenular functional connections are associated with depression state and modulated by ketamine.
Chen C; Wang M; Yu T; Feng W; Xu Y; Ning Y; Zhang B
J Affect Disord; 2024 Jan; 345():177-185. PubMed ID: 37879411
[TBL] [Abstract][Full Text] [Related]
14. Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder.
Liu H; Wang C; Lan X; Li W; Zhang F; Hu Z; Ye Y; Ning Y; Zhou Y
Eur Psychiatry; 2024 Apr; 67(1):e33. PubMed ID: 38572583
[TBL] [Abstract][Full Text] [Related]
15. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
Siegel JS; Palanca BJA; Ances BM; Kharasch ED; Schweiger JA; Yingling MD; Snyder AZ; Nicol GE; Lenze EJ; Farber NB
Psychopharmacology (Berl); 2021 Apr; 238(4):1157-1169. PubMed ID: 33483802
[TBL] [Abstract][Full Text] [Related]
16. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Li CT; Chen MH; Lin WC; Hong CJ; Yang BH; Liu RS; Tu PC; Su TP
Hum Brain Mapp; 2016 Mar; 37(3):1080-90. PubMed ID: 26821769
[TBL] [Abstract][Full Text] [Related]
17. Abnormal habenula functional connectivity characterizes treatment-resistant depression.
Barreiros AR; Breukelaar I; Mayur P; Andepalli J; Tomimatsu Y; Funayama K; Foster S; Boyce P; Malhi GS; Harris A; Korgaonkar MS
Neuroimage Clin; 2022; 34():102990. PubMed ID: 35305499
[TBL] [Abstract][Full Text] [Related]
18. Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration.
Evans JW; Szczepanik J; Brutsché N; Park LT; Nugent AC; Zarate CA
Biol Psychiatry; 2018 Oct; 84(8):582-590. PubMed ID: 29580569
[TBL] [Abstract][Full Text] [Related]
19. Habenular connectivity may predict treatment response in depressed psychiatric inpatients.
Gosnell SN; Curtis KN; Velasquez K; Fowler JC; Madan A; Goodman W; Salas R
J Affect Disord; 2019 Jan; 242():211-219. PubMed ID: 30195174
[TBL] [Abstract][Full Text] [Related]
20. The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
Niciu MJ; Iadarola ND; Banerjee D; Luckenbaugh DA; Park M; Lener M; Park L; Ionescu DF; Ballard ED; Brutsche NE; Akula N; McMahon FJ; Machado-Vieira R; Nugent AC; Zarate CA
J Psychopharmacol; 2017 Dec; 31(12):1570-1577. PubMed ID: 29039254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
